Discovery of novel paeonol-based derivatives against skin inflammation in vitro and in vivo

References

• Jinlian L, Yingbin Z, Chunbo W. P38 mapk in regulating cellular responses to ultraviolet radiation. J Biomed Sci 2007;14:303–12.
   PubMed Web of Science ®Google Scholar
• Han ZP, Li LZ, Huang YY, et al. Pbk/topk: a therapeutic target worthy of attention. Cells 2021;10:371.
   PubMed Web of Science ®Google Scholar
• Matsuo Y, Park JH, Miyamoto T, et al. Topk inhibitor induces complete tumor regression in xenograft models of human cancer through inhibition of cytokinesis. Sci Transl Med 2014;6:259ra145.
   PubMed Web of Science ®Google Scholar
• Park JH, Lin ML, Nishidate T, et al. Pdz-binding kinase/t-lak cell-originated protein kinase, a putative cancer/testis antigen with an oncogenic activity in breast cancer. Cancer Res 2006;66:9186–95.
   PubMed Web of Science ®Google Scholar
• Zhu F, Zykova TA, Kang BS, et al. Bidirectional signals transduced by topk-erk interaction increase tumorigenesis of hct116 colorectal cancer cells. Gastroenterology 2007;133:219–31.
   PubMed Web of Science ®Google Scholar
• Shih MC, Chen JY, Wu YC, Jan YH, et al. Topk/pbk promotes cell migration via modulation of the pi3k/pten/akt pathway and is associated with poor prognosis in lung cancer. Oncogene 2012;31:2389–400.
   PubMed Web of Science ®Google Scholar
• Chen F, Li RW, Wang CJ, et al. T-lak cell-originated protein kinase is essential for the proliferation of hepatocellular carcinoma smmc-7721 cells. Cell Biochem Funct 2013;31:736–42.
   PubMed Web of Science ®Google Scholar
• Fu XR, Zhao R, Yoon G, et al. 3-deoxysappanchalcone inhibits skin cancer proliferation by regulating t-lymphokine-activated killer cell-originated protein kinase in vitro and in vivo. Front Cell Dev Biol 2021;9:638174.
   PubMed Web of Science ®Google Scholar
• Ikeda Y, Park JH, Miyamoto T, et al. T-lak cell-originated protein kinase (topk) as a prognostic factor and a potential therapeutic target in ovarian cancer. Clin Cancer Res 2016;22:6110–7.
   PubMed Web of Science ®Google Scholar
• Ishikawa C, Senba M, Mori N. Mitotic kinase pbk/topk as a therapeutic target for adult T-cell leukemia/lymphoma. Int J Oncol 2018;53:801–14.
   PubMed Web of Science ®Google Scholar
• Cuadrado A, Nebreda AR. Mechanisms and functions of p38 mapk signalling. Biochem J 2010;429:403–17.
   PubMed Web of Science ®Google Scholar
• Guan PP, Wang XB, Jiang Y, et al. The anti-inflammatory effects of jiangrines from jiangella alba through inhibition of p38 and NF-κB signaling pathways. Bioorg Chem 2020;95:103507.
   PubMed Web of Science ®Google Scholar
• Su XD, Jang HJ, Li HX, et al. Identification of potential inflammatory inhibitors from aster tataricus. Bioorg Chem 2019;92:103208.
   PubMed Web of Science ®Google Scholar
• Li SQ, Zhu F, Zykova T, et al. T-lak cell-originated protein kinase (topk) phosphorylation of mkp1 protein prevents solar ultraviolet light-induced inflammation through inhibition of the p38 protein signaling pathway. J Biol Chem 2011;286:29601–9.
   PubMed Web of Science ®Google Scholar
• Lau CH, Chan CM, Chan YW, et al. Pharmacological investigations of the anti-diabetic effect of cortex moutan and its active component paeonol. Phytomedicine 2007;14:778–84.
   PubMed Web of Science ®Google Scholar
• Nizamutdinova IT, Oh HM, Min YN, et al. Paeonol suppresses intercellular adhesion molecule-1 expression in tumor necrosis factor-alpha-stimulated human umbilical vein endothelial cells by blocking p38, erk and nuclear factor-kappab signaling pathways. Int Immunopharmacol 2007;7:343–50.
   PubMed Web of Science ®Google Scholar
• Xue P, Wang Y, Zeng F, et al. Paeonol suppresses solar ultraviolet-induced skin inflammation by targeting t-lak cell-originated protein kinase. Oncotarget 2017;8:27093–104.
   PubMed Web of Science ®Google Scholar
• Sun GP, Wang H, Xu SP, et al. Anti-tumor effects of paeonol in a hepa-hepatoma bearing mouse model via induction of tumor cell apoptosis and stimulation of il-2 and tnf-alpha production. Eur J Pharmacol 2008;584:246–52.
   PubMed Web of Science ®Google Scholar
• Jin X, Wang J, Xia ZM, et al. Anti-inflammatory and anti-oxidative activities of paeonol and its metabolites through blocking mapk/erk/p38 signaling pathway. Inflammation 2016;39:434–46.
   PubMed Web of Science ®Google Scholar
• Tang K, Jiang Y, Zhang HW, et al. Design, synthesis of cinnamyl-paeonol derivatives with 1, 3-dioxypropyl as link arm and screening of tyrosinase inhibition activity in vitro. Bioorg Chem 2021;106:104512.
   PubMed Web of Science ®Google Scholar
• Huang LG, Zhang BS, Yang Y, et al. Synthesis and anti-inflammatory activity of paeonol analogues in the murine model of complete freund's adjuvant induced arthritis. Bioorg Med Chem Lett 2016;26:5218–21.
   PubMed Web of Science ®Google Scholar
• Hu YS, Han X, Yu PJ, et al. Novel paeonol derivatives: design, synthesis and anti-inflammatory activity in vitro and in vivo. Bioorg Chem 2020;98:103735.
   PubMed Web of Science ®Google Scholar
• Ghosh AK, Brindisi M. Urea derivatives in modern drug discovery and medicinal chemistry. J Med Chem 2020;63:2751–88.
   PubMedGoogle Scholar
• Chen LZ, Sun WW, Bo L, et al. New arylpyrazoline-coumarins: synthesis and anti-inflammatory activity. Eur J Med Chem 2017;138:170–81.
   PubMed Web of Science ®Google Scholar
• Yao RS, Li F, Deng SS, Zou GY. Synthesis of mononitrified and dinitrified derivatives of paeonol(in Chinese). J Hefei Univ Technol 2009;32:177–80.
   Google Scholar
• Nagy G, Clark JM, Buzas EI, et al. Nitric oxide, chronic inflammation and autoimmunity. Immunol Lett 2007;111:1–5.
   PubMed Web of Science ®Google Scholar
• Philkhana SC, Verma AK, Jachak GR, et al. Identification of new anti-inflammatory agents based on nitrosporeusine natural products of marine origin. Eur J Med Chem 2017;135:89–109.
   PubMed Web of Science ®Google Scholar
• Muller K, Faeh C, Diederich F. Fluorine in pharmaceuticals: looking beyond intuition. Science 2007;317:1881–6.
   PubMed Web of Science ®Google Scholar
• Grover J, Kumar V, Singh V, et al. Synthesis, biological evaluation, molecular docking and theoretical evaluation of admet properties of nepodin and chrysophanol derivatives as potential cyclooxygenase (cox-1, cox-2) inhibitors. Eur J Med Chem 2014;80:47–56.
   PubMed Web of Science ®Google Scholar
• Wu MF, Ma J, Ji LJ, et al. Design, synthesis, and biological evaluation of rutacecarpine derivatives as multitarget-directed ligands for the treatment of alzheimer's disease. Eur J Med Chem 2019;177:198–211.
   PubMed Web of Science ®Google Scholar
• Finch PW, Murphy F, Cardinale I, Krueger JG. Altered expression of keratinocyte growth factor and its receptor in psoriasis. Am J Pathol 1997;151:1619–28.
   PubMed Web of Science ®Google Scholar
• Molina DM, Jafari R, Ignatushchenko M, et al. Monitoring drug target engagement in cells and tissues using the cellular thermal shift assay. Science 2013;341:84–7.
   PubMed Web of Science ®Google Scholar
• Seol MA, Park JH, Jeong JH, et al. Role of topk in lipopolysaccharide-induced breast cancer cell migration and invasion. Oncotarget 2017;8:40190–203.
   PubMedGoogle Scholar
• Park JH, Jeong YJ, Won HK, et al. Activation of topk by lipopolysaccharide promotes induction of inducible nitric oxide synthase through NF-κB activity in leukemia cells. Cell Signal 2014;26:849–56.
   PubMed Web of Science ®Google Scholar
• Kuo LJ, Yang LX. Gamma-h2ax - a novel biomarker for DNA double-strand breaks. In Vivo 2008;22:305–9.
   PubMed Web of Science ®Google Scholar
• Gilliet M, Conrad C, Geiges M, et al. Psoriasis triggered by toll-like receptor 7 agonist Imiquimod in the presence of dermal plasmacytoid dendritic cell precursors. Arch Dermatol 2004;140:1490–5.
   PubMed Web of Science ®Google Scholar
• Flutter B, Nestle FO. Tlrs to cytokines: mechanistic insights from the Imiquimod mouse model of psoriasis. Eur J Immunol 2013;43:3138–46.
   PubMed Web of Science ®Google Scholar